- Home
- RGS vs INKT Comparison
RGS vs INKT Comparison
Compare RGS & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGS | INKT |
|---|---|---|
| Founded | 1922 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 57.6M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RGS | INKT |
|---|---|---|
| Price | $23.00 | $11.07 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 13.3K | 7.8K |
| Earning Date | 05-07-2026 | 03-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.24 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $210,134,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $35.34 | ★ N/A |
| Revenue Growth | ★ 3.52 | N/A |
| 52 Week Low | $15.00 | $6.66 |
| 52 Week High | $31.50 | $76.00 |
Technical Indicators
Market Signals| Indicator | RGS | INKT |
|---|---|---|
| Relative Strength Index (RSI) | 43.75 | 44.71 |
| Support Level | $21.67 | $10.96 |
| Resistance Level | $23.27 | $11.36 |
| Average True Range (ATR) | 0.84 | 0.34 |
| MACD | 0.16 | -0.01 |
| Stochastic Oscillator | 51.44 | 44.86 |
Price Performance
Historical ComparisonAbout RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.